Table 3 Patient characteristics (N = 57)
From: GLA:D® Back Australia: a mixed methods feasibility study for implementation
Total patients | Baseline N (%) (unless other specified) |
|---|---|
Female | 34 (66.7%) |
Age, mean (SD) years | 56.6 (14.1%) |
Height, mean (SD) cm | 167 (17.5%) |
Weight, mean (SD) kg | 85 (22.5%) |
Level of education | |
No qualification | 1 (2%) |
Vocational training | 11 (22%) |
Higher school education (year 10) | 7 (14%) |
Higher school education (year 12) | 4 (8%) |
Medium higher education (e.g., Bachelors) | 22 (44%) |
Long higher education (e.g., Masters or PhD) | 4 (8%) |
Employment status | |
Full-time | 16 (33.3%) |
Part-time | 8 (16.7%) |
Casual | 4 (8.3%) |
Unemployed | 1 (2.1%) |
Retired | 16 (33.3%) |
Housewife/other | 3 (6.3%) |
Clinical symptoms/pain duration | |
0–2 weeks | 3 (5.9%) |
2–4 weeks | 0 (0%) |
4–12 weeks | 6 (11.8%) |
3–12 months | 12 (23.5%) |
> 1 year | 30 (58.8%) |
Previous episodes (n = 51) | |
0 | 10 (19.6%) |
1 | 6 (11.8%) |
2–3 | 11 (21.6%) |
> 3 | 24 (47.1%) |
Missing | 6 |
Time since treatment initiated (n = 51) | |
< 2 weeks | 5 (9.8%) |
2–4 weeks | 4 (7.8%) |
> 4 weeks | 43 (82.4%) |
Missing | 6 |
No. of healthcare visits for low back pain (n = 51) | |
1 | 20 (39.2%) |
2–5 | 23 (45.1%) |
6–10 | 7 (13.7%) |
> 10 | 1 (2%) |
Missing | 6 |
Pain medication (n = 51) | |
None | 29 (56.9%) |
Over the counter | 15 (29.4%) |
Prescription | 7 (13.7%) |
Missing | 6 |
STarT Back risk (n = 50) | |
Low | 5 (10%) |
Medium | 19 (39%) |
High | 25 (51%) |
Missing | 7 |